Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 1551 | 2020 |
The landscape of genomic alterations across childhood cancers SN Gröbner, BC Worst, J Weischenfeldt, I Buchhalter, K Kleinheinz, ... Nature 555 (7696), 321-327, 2018 | 1327 | 2018 |
The whole-genome landscape of medulloblastoma subtypes PA Northcott, I Buchhalter, AS Morrissy, V Hovestadt, J Weischenfeldt, ... Nature 547 (7663), 311-317, 2017 | 973 | 2017 |
Patterns of somatic structural variation in human cancer genomes Y Li, ND Roberts, JA Wala, O Shapira, SE Schumacher, K Kumar, ... Nature 578 (7793), 112-121, 2020 | 722 | 2020 |
Variation in transcription factor binding among humans M Kasowski, F Grubert, C Heffelfinger, M Hariharan, A Asabere, ... Science 328 (5975), 232-235, 2010 | 710 | 2010 |
Analyses of non-coding somatic drivers in 2,658 cancer whole genomes E Rheinbay, MM Nielsen, F Abascal, JA Wala, O Shapira, G Tiao, ... Nature 578 (7793), 102-111, 2020 | 521 | 2020 |
A dual program for translation regulation in cellular proliferation and differentiation H Gingold, D Tehler, NR Christoffersen, MM Nielsen, F Asmar, ... Cell 158 (6), 1281-1292, 2014 | 496 | 2014 |
Coordinated effects of sequence variation on DNA binding, chromatin structure, and transcription H Kilpinen*, SM Waszak*, AR Gschwind*, SK Raghav, RM Witwicki, ... Science 342 (6159), 744-747, 2013 | 403 | 2013 |
Active medulloblastoma enhancers reveal subgroup-specific cellular origins CY Lin, S Erkek, Y Tong, L Yin, AJ Federation, M Zapatka, P Haldipur, ... Nature 530 (7588), 57-62, 2016 | 398 | 2016 |
Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking J Weischenfeldt, T Dubash, AP Drainas, BR Mardin, Y Chen, AM Stütz, ... Nature genetics 49 (1), 65-74, 2017 | 384 | 2017 |
Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort SM Waszak, PA Northcott, I Buchhalter, GW Robinson, C Sutter, ... The Lancet Oncology 19 (6), 785-798, 2018 | 359 | 2018 |
Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition B Rodriguez-Martin, EG Alvarez, A Baez-Ortega, J Zamora, F Supek, ... Nature Genetics 52 (3), 306-319, 2020 | 349 | 2020 |
Genomic basis for RNA alterations in cancer PCAWG Transcriptome Core Group, C Calabrese, NR Davidson, ... Nature 578 (7793), 129-136, 2020 | 332* | 2020 |
Molecular evolution of early-onset prostate cancer identifies molecular risk markers and clinical trajectories C Gerhauser, F Favero, T Risch, R Simon, L Feuerbach, Y Assenov, ... Cancer Cell 34 (6), 996-1011, 2018 | 243 | 2018 |
Population variation and genetic control of modular chromatin architecture in humans SM Waszak, O Delaneau, AR Gschwind, H Kilpinen, SK Raghav, ... Cell 162 (5), 1039-1050, 2015 | 240 | 2015 |
Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial GW Robinson, VA Rudneva, I Buchhalter, CA Billups, SM Waszak, ... The Lancet Oncology 19 (6), 768-784, 2018 | 209 | 2018 |
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns W Jiao, G Atwal, P Polak, R Karlic, E Cuppen, A Danyi, J de Ridder, ... Nature communications 11 (1), 728, 2020 | 184 | 2020 |
Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis J Carlevaro-Fita, A Lanzós, L Feuerbach, C Hong, D Mas-Ponte, ... Communications Biology 3 (1), 1-16, 2020 | 169 | 2020 |
Integrative pathway enrichment analysis of multivariate omics data M Paczkowska, J Barenboim, N Sintupisut, NS Fox, H Zhu, D Abd-Rabbo, ... Nature Communications 11 (1), 1-16, 2020 | 144 | 2020 |
A cell-based model system links chromothripsis with hyperploidy BR Mardin, AP Drainas, SM Waszak, J Weischenfeldt, M Isokane, ... Molecular systems biology 9 (1), 828, 2015 | 144 | 2015 |